Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of TIM3 2′-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy

14 Dec 2015

Abstract excerpt

// Sandra Hervas-Stubbs 1, 2, * , Mario M. Soldevilla 2, 3 , Helena Villanueva 2, 3 , Uxua Mancheño 1, 2 , Maurizio Bendandi 4 , Fernando Pastor 2, 3, * 1 Program Immunology and Immunotherapy, Centro de Investigaciones Medicas Aplicadas (CIMA), Pamplona, Spain 2 Instituto de Investigación Sanitaria de Navarra (IDISNA), Recinto de Complejo Hospitalario de Navarra, Pamplona, Spain 3 Program of Molecular Therapies,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced biosensing and bioanalysis techniques
Share to Bacteriophages and microbial interactions
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26683225
DOI: 10.18632/oncotarget.6608

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 12 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of TIM3 2′-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapyPMID 26683225Read ↗

Aptamers and antibodies: rivals or allies in cancer targeted therapy?Semantic proximity Read ↗

Identification and Engineering of Aptamers for Theranostic Application in Human Health and DisordersSemantic proximity Read ↗

Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA)Semantic proximity Read ↗

Development of a DNA Aptamer‐Based Approach to Noninvasively Image CAR‐T Cells In Vivo and Traceless Enrichment In VitroSemantic proximity Read ↗

A Highlight of Recent Advances in Aptamer Technology and Its ApplicationSemantic proximity Read ↗

Phage Display-Based Nanotechnology Applications in Cancer ImmunotherapySemantic proximity Read ↗

Aptamer-Based Probes for Cancer Diagnostics and TreatmentSemantic proximity Read ↗

Targeted knockdown of Tim3 by short hairpin RNAs improves the function of anti-mesothelin CAR T cellsSemantic proximity Read ↗

Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers MatterSemantic proximity Read ↗

Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive CancerSemantic proximity Read ↗

Targeting hepatocellular carcinoma with aptamers: from biomarker detection to therapeutic applicationsSemantic proximity Read ↗

Nucleic Acid-Based Aptamers: Applications, Development and Clinical TrialsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.